M366

Charleston Laboratories, Inc · Phase 1 active Small molecule

At a glance

Generic name	M366
Also known as	Low-dose M366 and High-dose M366
Sponsor	Charleston Laboratories, Inc
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Study in Opioid-Experienced, Non-Dependent Recreational Drug Users to Determine the Abuse Potential and Safety of CL-108 Tablets Administered Via the Oral Route (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

M366 CI brief — competitive landscape report
M366 updates RSS · CI watch RSS
Charleston Laboratories, Inc portfolio CI